MARK OLDAKOWSKI - 15 Feb 2022 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role
Chief Operating Officer
Signature
/s/ R. Erik Holmlin, Attorney-in-Fact
Issuer symbol
BNGO
Transactions as of
15 Feb 2022
Transactions value $
$0
Form type
4
Filing time
15 Feb 2022, 20:06:52 UTC
Previous filing
14 May 2021
Next filing
16 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNGO Stock Option (Right to Buy) Award $0 +650K $0.00 650K 15 Feb 2022 Common Stock 650K $2.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2022 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.